Unichem receives ANDA approval for Irbesartan, Hydrochlorothiazide Tablets

20 Sep 2017 Evaluate

Unichem Laboratories has received ANDA approval from the United States Food and Drug Administration (USFDA) for Irbesartan and Hydrochlorothiazide Tablets USP, 150 mg/12.5 mg, and 300 mg/12.5 mg, which are therapeutically equivalent to Avalide Tablets 150 mg/12.5 mg, and 300 mg/ 12.5 mg of Sanofi-Aventis U.S. LLC.

Irbesartan and Hydrochlorothiazide is a combination of Irbesartan, an angiotensin II receptor antagonist and Hydrochlorothiazide, a thiazide diuretic. This product is indicated for hypertension in patients not adequately controlled with monotherapy and also as initial therapy in patients with hypertension likely to need multiple drugs to achieve their blood pressure goals. The product will be commercialized from Unichem's Ghaziabad plant. Active Pharmaceutical Ingredient will also be made in house at Pithampur/Roha API Plant(s).

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.

Unichem Lab Share Price

372.30 -6.25 (-1.65%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×